v3.26.1
Other interim disclosures (Details 4)
€ in Millions, $ in Millions
6 Months Ended
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2026
EUR (€)
Dec. 31, 2025
USD ($)
Disclosure of detailed information about borrowings [line items]        
Bonds issued in the period $ 12,849      
Long-term financial debt with a carrying amount 5,700   € 5,000 $ 3,900
Net investment hedge recognized in the consolidated income statement $ 0 $ 0    
SOFR + 0.65% USD 500 million 2026/2029 Novartis Capital Corporation, New York, United States, issued at 100.000% [member]        
Disclosure of detailed information about borrowings [line items]        
Borrowings, interest rate basis SOFR      
Borrowings, adjustment to interest rate basis 65.00%   65.00%  
Borrowings, original currency USD      
Notional amount $ 500      
Borrowings, issuance date 2026      
Borrowings, maturity year 2029      
Borrowings, issuer Novartis Capital Corporation, New York, United States      
Borrowings, issue price 100.00%      
Bonds issued $ 499      
4.100% USD 1 250 million 2026/2029 Novartis Capital Corporation, New York, United States, issued at 99.883% [member]        
Disclosure of detailed information about borrowings [line items]        
Borrowings, coupon 4.10%   4.10%  
Borrowings, original currency USD      
Notional amount $ 1,250      
Borrowings, issuance date 2026      
Borrowings, maturity year 2029      
Borrowings, issuer Novartis Capital Corporation, New York, United States      
Borrowings, issue price 99.883%      
Bonds issued $ 1,247      
4.400% USD 1 750 million 2026/2031 Novartis Capital Corporation, New York, United States, issued at 99.960% [member]        
Disclosure of detailed information about borrowings [line items]        
Borrowings, coupon 4.40%   4.40%  
Borrowings, original currency USD      
Notional amount $ 1,750      
Borrowings, issuance date 2026      
Borrowings, maturity year 2031      
Borrowings, issuer Novartis Capital Corporation, New York, United States      
Borrowings, issue price 99.96%      
Bonds issued $ 1,746      
4.600% USD 2 000 million 2026/2033 Novartis Capital Corporation, New York, United States, issued at 99.574% [member]        
Disclosure of detailed information about borrowings [line items]        
Borrowings, coupon 4.60%   4.60%  
Borrowings, original currency USD      
Notional amount $ 2,000      
Borrowings, issuance date 2026      
Borrowings, maturity year 2033      
Borrowings, issuer Novartis Capital Corporation, New York, United States      
Borrowings, issue price 99.574%      
Bonds issued $ 1,986      
4.900% USD 2 250 million 2026/2036 Novartis Capital Corporation, New York, United States, issued at 99.719% [member]        
Disclosure of detailed information about borrowings [line items]        
Borrowings, coupon 4.90%   4.90%  
Borrowings, original currency USD      
Notional amount $ 2,250      
Borrowings, issuance date 2026      
Borrowings, maturity year 2036      
Borrowings, issuer Novartis Capital Corporation, New York, United States      
Borrowings, issue price 99.719%      
Bonds issued $ 2,237      
5.600% USD 1 000 million 2026/2046 Novartis Capital Corporation, New York, United States, issued at 99.536% [member]        
Disclosure of detailed information about borrowings [line items]        
Borrowings, coupon 5.60%   5.60%  
Borrowings, original currency USD      
Notional amount $ 1,000      
Borrowings, issuance date 2026      
Borrowings, maturity year 2046      
Borrowings, issuer Novartis Capital Corporation, New York, United States      
Borrowings, issue price 99.536%      
Bonds issued $ 990      
5.700% USD 2 250 million 2026/2056 Novartis Capital Corporation, New York, United States, issued at 99.120% [member]        
Disclosure of detailed information about borrowings [line items]        
Borrowings, coupon 5.70%   5.70%  
Borrowings, original currency USD      
Notional amount $ 2,250      
Borrowings, issuance date 2026      
Borrowings, maturity year 2056      
Borrowings, issuer Novartis Capital Corporation, New York, United States      
Borrowings, issue price 99.12%      
Bonds issued $ 2,216      
3.100% EUR 600 million 2026/2032 of Novartis Finance S.A., Luxembourg, Luxembourg issued at 99.525% [member]        
Disclosure of detailed information about borrowings [line items]        
Borrowings, coupon 3.10%   3.10%  
Borrowings, original currency EUR      
Notional amount | €     € 600  
Borrowings, issuance date 2026      
Borrowings, maturity year 2032      
Borrowings, issuer Novartis Finance S.A., Luxembourg, Luxembourg      
Borrowings, issue price 99.525%      
Bonds issued $ 679      
3.500% EUR 600 million 2026/2035 of Novartis Finance S.A., Luxembourg, Luxembourg issued at 99.757% [member]        
Disclosure of detailed information about borrowings [line items]        
Borrowings, coupon 3.50%   3.50%  
Borrowings, original currency EUR      
Notional amount | €     € 600  
Borrowings, issuance date 2026      
Borrowings, maturity year 2035      
Borrowings, issuer Novartis Finance S.A., Luxembourg, Luxembourg      
Borrowings, issue price 99.757%      
Bonds issued $ 681      
4.000% EUR 500 million 2026/2041 of Novartis Finance S.A., Luxembourg, Luxembourg issued at 99.833% [member]        
Disclosure of detailed information about borrowings [line items]        
Borrowings, coupon 4.00%   4.00%  
Borrowings, original currency EUR      
Notional amount | €     € 500  
Borrowings, issuance date 2026      
Borrowings, maturity year 2041      
Borrowings, issuer Novartis Finance S.A., Luxembourg, Luxembourg      
Borrowings, issue price 99.833%      
Bonds issued $ 568